Tumours with both BRAF mutation and MSI had the lowest risk for dissemination also marginally significant for lower risk for disease recurrence in stages II and III (Table 3 ).
← all excerpts
Microsatellite instability and mutations in BRAF and KRAS are significant predictors of disseminated disease in colon cancer.
1
—
—